# Immunotherapy with Autologous Tregs in T1DM

> **NCT06708780** · PHASE1 · RECRUITING · sponsor: **The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School** · enrollment: 20 (estimated)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **BIOLOGICAL:** Ex vivo Expanded Human Autologous Regulatory T Cells
- **OTHER:** Routine Care

## Key facts

- **NCT ID:** NCT06708780
- **Lead sponsor:** The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-12
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-11-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06708780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06708780, "Immunotherapy with Autologous Tregs in T1DM". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06708780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*